A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. - sprookjes - yvandenbroek - TriplyDB

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.

http://www.wikidata.org/entity/Q34990151

about

Animal Models for HIV Cure Research Quantification of viral infection dynamics in animal experiments Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies Recent developments in human immunodeficiency virus-1 latency research Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research An "escape clock" for estimating the turnover of SIV DNA in resting CD4⁺ T cells Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution Eradication therapies for HIV Infection: time to begin again.Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques TGFβ-Mediated Downregulation of Thrombopoietin Is Associated With Platelet Decline in Asymptomatic SIV Infection Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA Emergence of CD4 independence envelopes and astrocyte infection in R5 simian-human immunodeficiency virus model of encephalitis.Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques.Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes Plasmodium infection reduces the volume of the viral reservoir in SIV-infected rhesus macaques receiving antiretroviral therapy Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.Translational challenges in targeting latent HIV infection and the CNS reservoir problem.Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.HIV eradication symposium: will the brain be left behind?Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouse Generation of HIV latency in humanized BLT mice.HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART.Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs.A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads Persistent Peripheral Nervous System Damage in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy

P2860

Q26767476-FE896ADB-938D-4872-A07C-FEBA03AE92F1 Q26824804-9C63A448-C695-47E0-B6D2-A309918E8AF4 Q26825814-CC3F3B92-365C-4F86-8834-151F5F961080 Q27013114-355E456F-1170-4E47-866A-0932B0DD0246 Q27323780-A302B355-3486-4BAB-8E33-974595F0413E Q27342233-960D7D72-A9D8-4EE2-A3C7-57408FFFC420 Q27344720-0901D258-0570-45E7-AD07-209E713AEF5D Q28077662-2AF8B1AB-4241-4DD9-B153-2F5EA97AE3FA Q28482134-15A93781-1B0F-4772-818E-0CAB560E0CD4 Q28539563-83698DD9-8D3A-4EB9-B43B-9B8A4B366EBA Q30399588-0CD74549-0B31-4889-BAD1-28D60E137592 Q30494064-A60C094B-273B-4968-A580-C23A9B12D0E4 Q33409074-F1CECAFC-0C24-40A9-B686-A854E1CFA88F Q33411414-FBA55128-C504-4BBF-9D70-4A17D2F35EA1 Q33604776-E7BC239C-2AEA-49DA-BB7A-B13D446AEDE0 Q33644248-E2E04B60-9825-4E7D-81D6-056514F5075F Q33676630-80FCC39F-3A8E-4EA1-85DC-B99E66738C53 Q33893665-152BAEE6-69AB-4FD9-8CF7-E4657BE52793 Q34057907-C2D47766-B4B0-4F9D-B14F-F850CB115998 Q34173947-66BBEB2F-0307-42E5-A9C6-876128DF5E9C Q34596417-0C57F573-DDD5-4BF3-AAFB-BCE6774ABD50 Q34636367-9A142DD1-516C-41F3-BC9E-AE396440885C Q34649701-680E9A9B-C354-4AAF-A4B1-BB340609C601 Q34722464-00157A20-530B-42A6-B966-68C300859A65 Q35009558-245BB0CD-B4B1-4985-9FD3-D24DE22FC0FC Q35009744-451C8F75-32FC-414F-84EE-48A0651C343B Q35088292-3C486B7D-5560-4745-B7B9-CE14C278C6EF Q35121645-A7E40F51-4BDC-4959-8E5A-E8C85C056FB1 Q35192975-BCA949BF-D411-4BC4-B7F8-E96D1E82298E Q35252186-B4894C09-DA05-4B14-BA4F-2C19F8AD96E1 Q35607587-F4EE6504-C206-4E33-985D-BF3ED2B43C14 Q35641179-18226079-3CC8-4955-B73A-DA8DCDA44CBF Q35665924-F71378D5-EB47-44B0-8BFF-F21C435F013A Q35666126-4D31D223-C53F-4596-B89A-C0FB8650EEF6 Q35680431-331594DD-04AE-4A53-B7CC-79C312A5B44C Q35883306-09882913-75A4-43FB-81CD-1BAA9C1CC7DD Q35912988-47CF5A81-D63B-40CB-9E87-6A3D53E6A1C6 Q36073562-77E8AADD-CB8C-4422-9074-5A5678B142A9 Q36149000-1B87D378-BC54-4CA0-9037-8241B730CBCB Q36167247-ECD44CC2-9D51-47B3-AEB3-999C124A1C01

P2860

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.

http://www.wikidata.org/entity/Q34990151

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A simian immunodeficiency viru ...... active antiretroviral therapy.

@ast

A simian immunodeficiency viru ...... active antiretroviral therapy.

@en

A simian immunodeficiency viru ...... active antiretroviral therapy.

@nl

type

label

A simian immunodeficiency viru ...... active antiretroviral therapy.

@ast

A simian immunodeficiency viru ...... active antiretroviral therapy.

@en

A simian immunodeficiency viru ...... active antiretroviral therapy.

@nl

prefLabel

A simian immunodeficiency viru ...... active antiretroviral therapy.

@ast

A simian immunodeficiency viru ...... active antiretroviral therapy.

@en

A simian immunodeficiency viru ...... active antiretroviral therapy.

@nl

P1433

Q34990151-E6B8B7B3-B94B-49F1-9BA2-581F19FF6761

P1476

Q34990151-60ABAD79-D953-4047-BD99-926AB5D4B21E

P2093

Q34990151-2F97AF57-D68F-4E08-9CC5-FD2FD81991DD

Q34990151-331BD38E-CA1C-40BE-97B8-2A1E8B7C9F40

Q34990151-431B1E5D-26D4-49F1-BD43-3C3E5186A0B4

Q34990151-8379E0AB-44E5-4403-945D-3D0BFF4FE5FE

Q34990151-C2A346B4-F9E3-4D52-8FE1-F868AB84B00D

Q34990151-D11080FD-CBD8-4B65-A287-BA6D18025DC4

Q34990151-E7599E9C-4FE3-4233-BDF8-4ECC148E87A0

P2860

Q34990151-002557F8-AFC8-47BC-A49C-A40F7C735DCA

Q34990151-04BB4CAA-DA9C-4577-B5F7-B58D4F805B51

Q34990151-0B586788-C76D-4CC5-BFB6-B785A9199717

Q34990151-0DFCCD8E-762B-45D3-8D24-23113525505D

Q34990151-0F44D11E-8473-4265-8BF2-1A3C3A92BECD

Q34990151-110BEFE9-FFE4-40ED-A870-8DB6F295518A

Q34990151-17264137-72B7-4FF4-A704-2D31BC811164

Q34990151-1D2749A8-1AB9-40D1-A017-5CDCCF9C9C97

Q34990151-1D4063F7-7CA3-4E18-AD3B-D8EE040BF7B8

Q34990151-1E527E20-8D32-45A9-B085-35D159495B8E

P304

Q34990151-DC72BDBA-42C5-494C-87BC-0BCBB96FC4C2

P31

Q34990151-01D8BAF8-3A80-485D-80F3-8BD91CF92518

P356

Q34990151-D4A2DBAA-C90A-47D6-9B18-1DC27FC5C4BD

P407

Q34990151-D403C4B9-3C21-4540-ABA8-DF3428321A0E

P433

Q34990151-0B0A83D1-83B2-4EDF-A222-820E64B4DFF0

P478

Q34990151-365C1526-A578-4B7B-A952-BFAEA2C4146B

P50

Q34990151-EBF24407-ADA9-4B13-967D-BAAC4771A362

P577

Q34990151-0DF23A4E-8BB2-43AD-8094-8768EDF12407

P698

Q34990151-BECF90E1-7BC3-4AD9-AB37-D12CEBEFC5B4

P921

Q34990151-20B5CD22-C7A5-4B9F-ADC8-B30DA974F7BA

Q34990151-F1BAE33F-CDD6-44D7-B395-93EB6FF0B2CD

P932

Q34990151-BD48C596-958E-4C87-AB22-D9284135908E

P356

P1433

Journal of Virology

P1476

A simian immunodeficiency viru ...... active antiretroviral therapy.

@en

P2093

Janice E Clements

http://www.w3.org/2001/XMLSchema#string

Jason B Dinoso

http://www.w3.org/2001/XMLSchema#string

Joel N Blankson

http://www.w3.org/2001/XMLSchema#string

Joseph L Mankowski

http://www.w3.org/2001/XMLSchema#string

Lucio Gama

http://www.w3.org/2001/XMLSchema#string

M Christine Zink

http://www.w3.org/2001/XMLSchema#string

S Alireza Rabi

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Viral dynamics in human immunodeficiency virus type 1 infection

P304

9247-9257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00840-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Robert F. Siliciano

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19570871

http://www.w3.org/2001/XMLSchema#string

P921

Simian immunodeficiency virus

antiretroviral drug

P932

2738256

http://www.w3.org/2001/XMLSchema#string